首页 | 本学科首页   官方微博 | 高级检索  
     


Early intervention for late‐onset ornithine transcarbamylase deficiency
Authors:Daisuke Fujisawa  Hiroshi Mitsubuchi  Shirou Matsumoto  Masanori Iwai  Kimitoshi Nakamura  Ryuji Hoshide  Nawomi Harada  Makoto Yoshino  Fumio Endo
Affiliation:1. Department of Pediatrics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan;2. Department of Pediatrics and Child Health, Kurume University of Medicine, Kurume, Japan;3. Division of Gene Therapy and Regenerative Medicine, Cognitive and Molecular Research Institute of Brain Diseases, Kurume University, Kurume, Japan
Abstract:We report the case of a family with late‐onset ornithine transcarbamylase deficiency (OTCD). Several family members had died from OTCD, and the c.221G>A, p.Lys221Lys mutation was detected at the 3′ end of exon 6 of OTC in the X‐chromosome of some members. We provided genetic counseling on pregnancy, delivery, and neonate management to a 4th‐generation female carrier and decided on metabolic management of her child from birth. Two male patients were diagnosed with late‐onset OTCD on the basis of blood amino acid and genetic analysis, and they received arginine supplementation from the asymptomatic, early neonatal period. These children grew and developed normally, without decompensation. Patients with late‐onset OTCD can and should be diagnosed and treated in the early neonatal period, especially those from families already diagnosed with late‐onset OTCD, and family members must be provided with genetic counseling.
Keywords:arginine supplementation  blood amino acid analysis  genetic analysis  genetic counseling  late‐onset ornithine transcarbamylase deficiency
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号